Inno Laser Technology Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100004LY4
CNY
85.28
-3.21 (-3.63%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

With a growth in Operating Profit of 367.16%, the company declared Outstanding results in Mar 26

  • The company has declared positive results for the last 3 consecutive quarters
  • OPERATING CASH FLOW(Y) Highest at CNY 55.84 MM
  • PRE-TAX PROFIT(Q) At CNY 12.36 MM has Grown at 270.62%
  • NET PROFIT(Q) At CNY 11.06 MM has Grown at 252.04%
2

Market Beating performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CNY 2,356 Million (Mid Cap)

stock-summary
P/E

219.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.15%

stock-summary
Debt Equity

-0.32

stock-summary
Return on Equity

6.20%

stock-summary
Price to Book

2.25

Revenue and Profits:
Net Sales:
115 Million
(Quarterly Results - Mar 2026)
Net Profit:
11 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
55.42%
0%
55.42%
6 Months
135.39%
0%
135.39%
1 Year
187.53%
0%
187.53%
2 Years
371.42%
0%
371.42%
3 Years
247.8%
0%
247.8%
4 Years
243.04%
0%
243.04%
5 Years
0%
0%
0.0%

Inno Laser Technology Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
7.37%
EBIT Growth (5y)
-31.55%
EBIT to Interest (avg)
-2.50
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.30
Sales to Capital Employed (avg)
0.44
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
31.31%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.21%
ROE (avg)
3.60%

Valuation key factors

Factor
Value
P/E Ratio
219
Industry P/E
Price to Book Value
8.58
EV to EBIT
618.01
EV to EBITDA
188.79
EV to Capital Employed
11.29
EV to Sales
16.68
PEG Ratio
0.13
Dividend Yield
0.04%
ROCE (Latest)
1.83%
ROE (Latest)
3.92%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Bullish
Bullish
OBV
Bullish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 35.53% vs 8.28% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 240.00% vs 48.98% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "115.20",
          "val2": "85.00",
          "chgp": "35.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "9.90",
          "val2": "-1.90",
          "chgp": "621.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.60",
          "val2": "0.40",
          "chgp": "50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "10.50",
          "val2": "-7.50",
          "chgp": "240.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "85.70%",
          "val2": "-137.30%",
          "chgp": "22.30%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 14.83% vs 21.52% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 163.48% vs 435.85% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "510.90",
          "val2": "444.90",
          "chgp": "14.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "60.70",
          "val2": "31.60",
          "chgp": "92.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.00",
          "val2": "1.10",
          "chgp": "-9.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-6.40",
          "val2": "0.10",
          "chgp": "-6,500.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "46.90",
          "val2": "17.80",
          "chgp": "163.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "41.20%",
          "val2": "-24.40%",
          "chgp": "6.56%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoYstock-summary

Mar'26
Mar'25
Change(%)
Net Sales
115.20
85.00
35.53%
Operating Profit (PBDIT) excl Other Income
9.90
-1.90
621.05%
Interest
0.20
0.20
Exceptional Items
0.60
0.40
50.00%
Consolidate Net Profit
10.50
-7.50
240.00%
Operating Profit Margin (Excl OI)
85.70%
-137.30%
22.30%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Mar 2026 is 35.53% vs 8.28% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 240.00% vs 48.98% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
510.90
444.90
14.83%
Operating Profit (PBDIT) excl Other Income
60.70
31.60
92.09%
Interest
1.00
1.10
-9.09%
Exceptional Items
-6.40
0.10
-6,500.00%
Consolidate Net Profit
46.90
17.80
163.48%
Operating Profit Margin (Excl OI)
41.20%
-24.40%
6.56%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 14.83% vs 21.52% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 163.48% vs 435.85% in Dec 2024

stock-summaryCompany CV
About Inno Laser Technology Co., Ltd. stock-summary
stock-summary
Inno Laser Technology Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available